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Esthesioneuroblastoma is an uncommon tumour of neuroectodermal origin. The authors describe a rare presentation of
an atypical esthesioneuroblastoma invading oral cavity. The clinical presentation, aetiology, diagnosis, and management
of this condition are discussed. The patient developed significant swelling in the right anterosuperior alveolar mucosa
and had moderate tooth mobility. Conventional x-rays and computed tomography revealed a large osteolytic lesion,
with imprecise limits. Histological findings along with immunohistochemical staining results and clinical features led to
the diagnosis of high-grade esthesioneuroblastoma. Local recurrences and neck metastasis were detected. The rare oral
findings produced delayed in diagnosis which may lead to a compromise in planning and execution of further radical
management and thus a poor prognosis.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1168853011139286.
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Esthesioneuroblastoma (ENB) is a rare and complex
tumour, representing the most undifferentiated end
of the spectrum of neuroendocrine tumours. The ag-
gressiveness of ENBs is partly due to their complex
anatomical location and non-specific symptoms that
lead to delay in the diagnosis. This study highlights the
characteristics of clinical, histopathological and immu-
nohistochemical features of ENB showing unusual oral
involvement and its importance in the differential diag-
nosis of sinonasal neuroendocrine malignancies and
maxillary neoplastic lesions.
ENB, also known as olfactory neuroblastoma, is an un-
common tumour of neuroectodermal origin. There re-
mains some controversy as to the origin of ENB, although
the most widely accepted opinion is that it arises from
basal olfactory epithelial stem cells, which would account
for the intimate relationship of most ENBs with the cribi-
form plate, the upper portions of the nasal septum, the su-
perior turbinates, the lateral nasal walls, and the anterior* Correspondence: sandra.zeidler@ufes.br
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article, unless otherwise stated.skull base. The olfactory epithelium is composed of bipolar
sensory neurons, supporting cells and basal cells that, be-
ing mitotically active, are deemed to be the ancestors of
the ENB [1,2].
The non-specific symptoms of nasal obstruction, re-
current epistaxis and anosmia and the special anatomical
location of the tumour often lead to a diagnosis of benign
paranasal disease, delaying the correct diagnosis [1].
Intraoral findings are uncommon. This is a case report of
an atypical esthesioneuroblastoma invading oral cavity.Case presentation
A 24-year-old female was referred to an Oral Medicine
Center complaining of paresthesia and tooth loosening,
related to a maxillary lump, with an evolution of at least
1 year and no previous history of trauma. In the medical
history of the patient there were no reports of viral in-
fections in childhood or other systemic abnormalities.
No family history of hereditary disease. She also denied
any alcohol consumption or tobacco use. Cervical lymph
node enlargement was not detected on palpation. Intraoral
examination revealed a swelling in the right anterosuperior
alveolar mucosa, which was hard on palpation, with mod-
erate tooth mobility. The initial differential diagnosis basedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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odontogenic cyst (Figure 1).
Conventional x-rays and computed tomography (CT)
revealed osteolytic lesion with imprecise limits (± 3.0 cm)
determining resorption of alveolar process and palatal
bone, soft tissue invasion and floating teeth features.
Superiorly, it extended into the nasal cavity, with partial
destruction of the nasal septum and inferior nasal turbin-
ate (Figures 1B-D and 2). An aspiration biopsy was nega-
tive and malignant neoplasm was considered probable
diagnosis.
Microscopic examination of the incisional biopsy and
surgical specimen revealed the proliferation of islands
and cords composed of small cells displaying either basa-
loid or fusiform morphology. Pleomorphic and hyperchro-
matic nuclei with a fine granular chromatin pattern, as
well as moderate mitoses and rare necrosis were observed.
Fibrous connective tissue or thick collagenized cellularized
stroma was visible between the islands and cords with lit-
tle inflammatory infiltrate. Prominent nucleoli, rosettes of
the Homer Wright type (pseudorosettes) or true rosettes
were infrequent, featuring Grade III according to Hyams’
histopathologic grading system (Figure 3) [3].
The histological similarities to malignant small round
cell tumours (e.g. neuroendocrine carcinoma) and basaloid
squamous cell carcinoma required the use of a broad im-
munohistochemical panel as an adjuvant technique in the
differential diagnosis. The tumour showed positive immu-
noreactivity to neuron-specific enolase (NSE) at 1:100
(clone BBS/NC/VI-H14, DAKO, Glostrup, Denmark),Figure 1 Clinical and radiographic features. (A) Intraoral appearance of
periapical radiographs revealed a radiolucent lesion extending from the up
suggesting involvement of the floor of the nasal cavity and ipsilateral maxi
floating teeth.synaptophysin (Syn) at 1:200 (polyclonal, Novocastra,
Newcastle, UK) and vimentin at 1:2000 (clone VIM3B4,
Novocastra), along with focal positive immunoreactivity
to cytokeratin at 1:800 (clone AE1/AE3, Novocastra) and
carcinoembryonic antigen (CEA) at 1:2000 (polyclonal,
DAKO). A few cells showed a positive reaction to S-100
protein at 1:600 (polyclonal, Novocastra), chromogranin A
at 1:400 (clone LK2H10, Novocastra) and p53 at 1:100
(clone DO-7, Novocastra). Immunohistochemical staining
was negative for neuroblastoma marker at 1:400 (clone
NB84a, DAKO) (Figure 3). Histological findings along with
immunohistochemical staining results and clinical features
led to the diagnosis of high-grade esthesioneuroblastoma.
The patient underwent partial maxillectomy and imme-
diate rehabilitation with obturator prostheses. Adjuvant
radiotherapy was given over 6 weeks with a total dose of
6000 Gy. The patient presented with two recurrences 12
and 22 months after radiotherapy. In the first recurrence
the patient underwent infrastructure maxillectomy. The
second recurrence was diagnosed and a CT scan revealed
neck metastasis. The patient refused further surgery and
palliative chemotherapy was initiated.
Discussion
Sinonasal neuroendocrine malignancies are complex and
rare, with ENB representing the most undifferentiated
end of the spectrum of neuroendocrine tumours. ENB
accounts for approximately 3% to 6% of nasal cavity and
paranasal sinus cancer cases, 0.3% of upper aerodigestive
tract malignancies and less than 1% of all head and neckthe neoplasm at first consultation. (B, C, D) Panoramic, occlusal and
per right first molar to the upper left canine, with imprecise limits,
llary sinus. Extensive bone resorption gave the appearance of
Figure 3 Histopathological and immunohistochemical findings. (A) Low-powered photomicrograph showing proliferation of islands and
cords composed of small cells displaying either basaloid or fusiform morphology, a thick collagenized cellularized stroma with little inflammatory
infiltrate. (B) In detail, neoplastic cells with pleomorphic and hyperchromatic nuclei. The cells in the tumour islands and cords were strongly positive for
enolase (NSE), synaptophysin (SYN) and vimentin (VIM3B4). Some positive expression was also observed in the stromal cells. (Haematoxylin-eosin, original
magnification x20[A], x100[B]; Immunohistochemical staining, original magnifications x40).
Figure 2 Tomographic characteristics. Axial scans (A1, B1) and coronal reformatted images (C1, D1) in bone window, and the same axial
(A2, B2) and coronal (C2, D2) slice levels in contrast-enhanced soft tissue window. (A, B) The views show that the right inferior nasal concha
was moderately increased in volume and tissue proliferation was observed in its anterior portion. (C, D) The nasal septum was partially destroyed.
The lesion had invaded the alveolar process and soft tissue. Contrast enhancement was moderate and homogenous.
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and occurs over a wide age range, though a bimodal
age distribution with an early peak from 11 to 20
and a later peak between 51 and 60 years of age has been
reported [2,4].
ENB is characterized by slow progression and locally
aggressive behaviour, which lead to long-term survival
but very frequent late local recurrence. The aggressive-
ness of ENBs is partly due to their complex anatomical
location, close to vital structures, which is associated
with non-specific symptoms that lead to delay in the
patient seeking diagnosis [1,5,6]. The reported case
revealed an atypical ENB identified by oral symptoms,
with radiographic images that suggested a maxillary neo-
plasm invading the nasal cavity. However, axial CT im-
ages suggested that the epicentre of the lesion was in the
nasal region and that it was invading the alveolar process
(Figure 2).
The diagnosis of ENB via light microscopy by itself
can be difficult since the tumour tends to exhibit little
or no differentiation. Pathological classification is chal-
lenging because the tumours must be differentiated from
other small cell neoplasms of the nasal cavity such as
Non-Hodgkin’s lymphoma, Ewing’s sarcoma, mucosal
malignant melanoma and neuroendocrine carcinomas
[2]. In this case, given the relation with the oral mucosa,
basaloid squamous cell carcinoma was also included in
the differential diagnosis.
The histopathological parameters that help in differen-
tiating these tumours include the pattern of tumour cell
arrangement, stroma, nuclear chromatin characteristics,
presence or absence of neuropil and resetting. The use
of a broad panel of antibodies in immunohistochemical
staining may help to establish a final diagnosis. ENB is
usually positive for general neuroendocrine markers,
such as neuron specific enolase (NSE), S-100 protein,
synaptophysin (Syn) and chromogranin. NSE is typically
the most positive immunohistochemical stain in ENB.
S-100 protein positive peripheral dendritic cells cor-
responding to Schwann cells may be present within the
neoplasm or at the edges of tumour nests. Positivity var-
ies in the cases reported in the literature for vimentin,
keratin, glial fibrillary acidic protein, and neurofilaments
[5,6]. In the reported case the tumour showed strong
positive expression of NSE, Syn and vimentin. Significant
correlation between CD44 expression and the stage of
the disease has been suggested to help predicting clinical
outcome. CD44s negative tumors are significantly corre-
lated with the lack of differentiation. Thus, overexpres-
sion of CD44s could be considered as a predictor of the
absence of infiltration of the tumour and neuroblastic
tumors subtypes of favorable prognosis [7].
The possibility of basaloid squamous cell carcinoma
and primitive neuroendocrine tumour was not supportedby immunohistochemistry, and this was reinforced by the
focal expression of carcinoembryonic antigen and pan-
cytokeratin. The small number of labeled cells at P53
suggested a more favorable prognosis in terms of tumour
proliferation [6].
The rates of primary tumour recurrence vary and most
of the case series show local recurrence rates of approxi-
mately 14 to 30%. The mean time to recurrence is 2
years, but recurrences can occur as late as 10 years after
the initial diagnosis, with approximately 50% of them
occurring after 5 years [1,5,6,8].
Craniofacial resection with definitive or adjuvant radio-
therapy has been used for local control. Chemotherapy can
be used in an adjuvant/neoadjuvant attempt and also in
the metastatic phase, or recurrent or advanced disease,
although its effectiveness has still not been established.
Such multimodality therapy has become the most common
approach to ENB [4,9-12].
The Kadish staging system is a clinically based staging
system for sinonasal tumors and the ENB herein de-
scribed was classified as Kadish stage C (extension of
tumour beyond the nasal cavity and paranasal sinuses)
[9,10]. However, sectional images showed local disease
in an uncommon location, the anterior part of the infer-
ior nasal concha extending to another atypical area –
the maxillary alveolar ridge. Due to the large number of
neoplasms and cystic lesions affecting the jaws, exten-
sion of the tumour into the oral cavity was causing tooth
mobility, mimicking a neoplasm of that region.
In this case report, the rare oral findings produced de-
layed in diagnosis leading to a compromise in planning
and execution of adequate management. Only another
two cases of ENB in the literature included intraoral
findings, confirming the importance of the knowledge
about different clinical presentations of ENB [13,14]. We
believe that the difficulty in diagnosis and inadequate
management due to atypical oral cavity localization may
lead to a compromise in planning and execution of fur-
ther radical management and thus a poor prognosis.
This highlights the importance of the dentist’s know-
ledge about different clinical presentations of ENB. The
two local recurrences of this reported case were also ob-
served primarily in the oral cavity. Despite surgery and
radiotherapy, cervical metastasis was detected 12 months
after the end of treatment. Based on the histological grad-
ing, the tumor of this patient can be categorized as high-
grade malignancy and along with advanced clinical stage
(Kadish C) may be associated with locoregional recurrence
and clinical spread of tumor.
Conclusions
In conclusion, this study highlights the characteristics of
clinical features of ENB showing oral involvement and
its importance in the differential diagnosis of sinonasal
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value as another atypical case of ENB and also has
teaching value for training in the differential diagnosis of
maxillary neoplastic lesions.
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